Brought to you by 
Aderis seeks to raise $75mm with IPO; postponed
29 Oct 2003
Executive Summary
Aderis Pharmaceuticals (formerly Discovery Therapeutics; small-molecule drugs for CNS, cardiovascular, and inflammatory disorders) has withdrawn its initial public offering filed in August, in which it hoped to raise $75mm. This is the second time the company postponed its IPO due to poor market conditions; it originally filed in early 2002, intending to bring in $100mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aderis seeks to raise $75mm with IPO; postponed
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice